Eidelman Virant Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Eidelman Virant Capital’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$17K	Hold	27,000	–	–	0.01%	175
2022 Q2	$63K	Hold	27,000	–	–	0.05%	167
2022 Q1	$109K	Hold	27,000	–	–	0.06%	168
2021 Q4	$219K	Buy	27,000 +9,500	+54%	+$111K	0.08%	169
2021 Q3	$342K	Hold	17,500	–	–	0.13%	135
2021 Q2	$236K	Buy	+17,500	New	+$207K	0.09%	149

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

SGCA

Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Eidelman Virant Capital's PLXP Position: Q3 2022 in Review

Eidelman Virant Capital held its PLx Pharma Inc. Common Stock (PLXP) position steady in Q3 2022 at 27,000 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #175.

Eidelman Virant Capital first reported a position in PLXP in Q2 2021 and has held it in 6 quarters since. The position peaked at $342K in Q3 2021. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

Eidelman Virant Capital held 27,000 shares of PLx Pharma Inc. Common Stock worth $17K as of Q3 2022.
Eidelman Virant Capital left its PLx Pharma Inc. Common Stock share count unchanged in Q3 2022.
PLx Pharma Inc. Common Stock made up 0.01% of Eidelman Virant Capital's portfolio in Q3 2022, its #175 holding.
Eidelman Virant Capital first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and has held it in 6 quarters since.
Eidelman Virant Capital's PLx Pharma Inc. Common Stock position peaked at $342K in Q3 2021.
40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on Eidelman Virant Capital's 13F filing for Q3 2022, filed 25 Oct 2022.